...
首页> 外文期刊>Medical science monitor : >Treatment of subjective tinnitus: a comparative clinical study of intratympanic steroid injection vs. oral carbamazepine
【24h】

Treatment of subjective tinnitus: a comparative clinical study of intratympanic steroid injection vs. oral carbamazepine

机译:主观耳鸣的治疗:鼓膜内类固醇注射与口服卡马西平的对比临床研究

获取原文
           

摘要

Background Over the last decade, more and more otologists have been using the intratympanic perfusion of steroids to treat SSHL, tinnitus, and vertigo. However, results of the treatment in the literature are controversial because most of the reports were retrospective and uncontrolled. Therefore a prospective random single-blind trial was conducted at the Affiliated Drum Tower Hospital of Nanjing University Medical School, P. R. China. The results were compared with oral carbamazepine treatment. Carbamazepine is a medication routinely used to treat tinnitus. Material and Method Seventy-nine patients (84 ears) with subjective tinnitus which failed to respond to a minimum of four-week systemic medical therapy were assigned to a study group and a control group by a random, single-blind method. The study group was further randomly divided into two subgroups. The participants in the study group received either 0.5-ml intratympanic injections of prednisolone (study group 1) or dexamethasone (study group 2). The patients in the control group only took carbamazepine. The effective rates at the end of the therapy and the control rates at the end of a six-month follow-up were analyzed statistically. Results There were no statistical differences in the effective and control rates among the three groups. Conclusions Intratympanic steroid injection has positive effects similar to those of oral carbamazepine in subjective tinnitus. Intratympanic steroid injection may be considered an alternative treatment for subjective tinnitus.
机译:背景技术在过去的十年中,越来越多的耳科医生一直在使用鼓膜内灌注类固醇来治疗SSHL,耳鸣和眩晕。但是,由于大多数报道都是回顾性的且不受控制,因此文献中的治疗结果存在争议。因此,前瞻性随机单盲试验是在中国南京大学医学院附属鼓楼医院进行的。将结果与口服卡马西平治疗进行比较。卡马西平是通常用于治疗耳鸣的药物。材料与方法将79例(84耳)主观耳鸣患者至少对4周的全身药物治疗无效,通过随机单盲方法将其分为研究组和对照组。研究组进一步随机分为两个亚组。研究组的参与者接受0.5 ml泼尼松龙的鼓膜内注射(研究组1)或地塞米松(研究组2)。对照组患者仅服用卡马西平。统计分析治疗结束时的有效率和六个月随访结束时的控制率。结果三组的有效率和控制率无统计学差异。结论鼓膜内类固醇注射对主观耳鸣具有与口服卡马西平相似的积极作用。鼓室内类固醇注射可能被认为是主观耳鸣的替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号